More than two years after the landmark case of collusion in the tissue paper market had seemingly concluded, a new possible complication in the case has been revealed. According to a report by Radio Bío Bío, the cartel also affected a third sector: the institutional clients segment. These may include considerable tenders with hospitals, clinics, restaurants, hotels, large companies and even public bodies.
The FNE, led by Felipe Irarrázabal, argued that the agency “investigated possible illegal behavior in the two channels through which this type of product is distributed: mass consumption and institutional.” He indicated that the first segment represents between 70% and 80% of the sector’s sales.
The entity stated that the accusation did not include possible infractions in the institutional channel, because “neither in the evidence seized nor in the multiple statements taken from executives did antecedents appear in addition to those provided by CMPC regarding the existence of an agreement with SCA to allocate customers in this channel. ” He added that “the evidence did not give an account of an agreement subsequent to 2009 or that had effects beyond that date”.
Full Content: Economía y Negocios
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Dismisses Antitrust Lawsuit Against Ivy League Over Athletic Scholarships
Oct 11, 2024 by
CPI
FTC and DOJ Revamp Merger Guidelines to Identify Illegal Transactions More Efficiently
Oct 11, 2024 by
CPI
US Consumer Watchdog Eyes Expansion of ‘Junk Fee’ Crackdown Ahead of 2024 Election
Oct 10, 2024 by
CPI
Brazil Proposes Reform to Competition Law Targeting Big Tech
Oct 10, 2024 by
CPI
Meta Enhances User Data Control, Resolving German Antitrust Dispute
Oct 10, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh